Frazier Life Sciences Management, L.P. Theseus Pharmaceuticals, Inc. Transaction History

Frazier Life Sciences Management, L.P.

  • $1.86 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$2.12 - $4.18 $275,903 - $543,997
-130,143 Reduced 5.79%
2,118,051 $8.58 Million
Q1 2023

May 15, 2023
BUY
$5.21 - $14.05 $4.43 Million - $11.9 Million
850,000 Added 60.79%
2,248,194 $20 Million
Q4 2022

Feb 03, 2023
BUY
$4.69 - $8.36 $6.56 Million - $11.7 Million
1,398,194 New
1,398,194 $6.96 Million

Others Institutions Holding THRX

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Theseus Pharmaceuticals, Inc.

THRX Quotes by TradingView
  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Frazier Life Sciences Management, L.P. Portfolio

Follow Frazier Life Sciences Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email